{
  "newsletter_id": "lai_weekly_v4_2025_12_22",
  "client_id": "lai_weekly_v4",
  "generated_at": "2025-12-22T09:29:35.098626Z",
  "period": {
    "start_date": "2025-12-22",
    "end_date": "2025-12-22"
  },
  "metrics": {
    "total_items": 5,
    "items_by_section": {
      "top_signals": 5,
      "partnerships_deals": 0,
      "regulatory_updates": 0,
      "clinical_updates": 0
    },
    "unique_sources": 2,
    "key_entities": {
      "companies": [
        "Teva",
        "Nanexa",
        "Medincell",
        "Teva Pharmaceuticals",
        "Moderna"
      ],
      "technologies": [
        "Long-Acting Injectable",
        "Once-Monthly",
        "Extended-Release Injectable",
        "PharmaShell®"
      ],
      "trademarks": [
        "PharmaShell®",
        "UZEDY®"
      ]
    }
  },
  "sections": [
    {
      "section_id": "top_signals",
      "title": "Top Signals – LAI Ecosystem",
      "items": [
        {
          "item_id": "press_corporate__medincell_20251222_1781cc",
          "title": "The FDA has approved an expanded indication for UZEDY® (risperidone) Extended-Release Injectable Sus",
          "score": 11.7,
          "published_at": "2025-12-22",
          "source_url": "https://www.medincell.com/wp-content/uploads/2025/10/MDC_UZEDY-BDI_EN_10102025_vf.pdf",
          "entities": {
            "companies": [],
            "technologies": [
              "Extended-Release Injectable"
            ],
            "trademarks": [
              "UZEDY®"
            ]
          }
        },
        {
          "item_id": "press_corporate__medincell_20251222_516562",
          "title": "Teva Pharmaceuticals has submitted a New Drug Application to the U.S. FDA for Olanzapine Extended-Re",
          "score": 11.2,
          "published_at": "2025-12-22",
          "source_url": "https://www.medincell.com/wp-content/uploads/2025/12/MDC_Olanzapine-NDA-filing_09122025_EN_vf-2.pdf",
          "entities": {
            "companies": [
              "Medincell",
              "Teva Pharmaceuticals"
            ],
            "technologies": [
              "Extended-Release Injectable",
              "Once-Monthly"
            ],
            "trademarks": []
          }
        },
        {
          "item_id": "press_corporate__nanexa_20251222_6f822c",
          "title": "Nanexa and Moderna have entered into a license and option agreement for the development of up to fiv",
          "score": 11.0,
          "published_at": "2025-12-22",
          "source_url": "https://nanexa.com/mfn_news/nanexa-and-moderna-enter-into-license-and-option-agreement-for-the-development-of-pharmashell-based-products/",
          "entities": {
            "companies": [
              "Nanexa",
              "Moderna"
            ],
            "technologies": [
              "PharmaShell®"
            ],
            "trademarks": [
              "PharmaShell®"
            ]
          }
        },
        {
          "item_id": "press_corporate__medincell_20251222_c147c4",
          "title": "Teva's UZEDY® continues strong growth, and the company is preparing for a US NDA submission for its ",
          "score": 9.0,
          "published_at": "2025-12-22",
          "source_url": "https://www.medincell.com/wp-content/uploads/2025/11/PR_MDC_Teva-earnings-Q3_2025_05112025_vf.pdf",
          "entities": {
            "companies": [
              "Teva"
            ],
            "technologies": [
              "Long-Acting Injectable"
            ],
            "trademarks": [
              "UZEDY®"
            ]
          }
        },
        {
          "item_id": "press_corporate__medincell_20251222_150759",
          "title": "Medincell, a biotech company, has been awarded a new grant to develop long-acting injectable formula",
          "score": 5.8,
          "published_at": "2025-12-22",
          "source_url": "https://www.medincell.com/wp-content/uploads/2025/11/MDC_Gates-Malaria_PR_24112025_vf.pdf",
          "entities": {
            "companies": [
              "Medincell"
            ],
            "technologies": [
              "Long-Acting Injectable"
            ],
            "trademarks": []
          }
        }
      ]
    }
  ],
  "bedrock_calls": {
    "tldr_generation": {
      "status": "success"
    },
    "introduction_generation": {
      "status": "success"
    }
  }
}